Sleeve Gastrectomy Severe Complications: Is It Always a Reasonable Surgical Option?

Moszkowicz, David; Arienzo, Roberto; Khettab, Idir; Rahmi, Gabriel; Zinzindohoué, Franck; Berger, Anne; Chevallier, Jean‐Marc

doi:10.1007/s11695-012-0860-4

Cited by 115 publications

(66 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, other published series on GF after LSG concerned fewer than 50 patients and thus were not highly powered from a statistical viewpoint [12,13]. In contrast, the greater number of patients with GF in the present study (n=91) enabled us to perform case-matching and thus reduce potential bias.…”

Section: Discussionmentioning

confidence: 83%

“…The first patients included in the LSG-control group were treated in 2010, which gave us some time to familiarize ourselves with use of the DPS. From 2010 onwards, a median of 14 patients per year were treated with a DPS (range [10][11][12][13][14][15][16][17][18][19]. Given the number of patients treated for GF, our level of experience has necessarily increased.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Does Somatostatin-14 Have an Impact on Gastric Fistula After Laparoscopic Sleeve Gastrectomy?

et al. 2014

View full text Add to dashboard Cite

The main complications following laparoscopic sleeve gastrectomy (LSG) is gastric fistula (GF). Gastric fistula is a rare but serious complication (affecting 2 % of LSGs). Somatostatin-14 and its analogs are mainly used in the prevention and curative treatment of digestive fistulas. These compounds inhibit secretions in the pancreas, stomach, and small intestine. Treatment with somatostatin-14 increases the spontaneous closure rate and reduces the closure time of postoperative digestive fistulas. However, the impact of somatostatin-14 on GF after LSG has not been studied. We report on a prospective, non-randomized, single-center, case-matched study of patients receiving somatostatin-14 after a post-LSG GF was discovered. Our results suggest that use of somatostatin-14 is associated with a shorter length of hospital stay and (perhaps) a shorter treatment period.

show abstract

Section: Discussionmentioning

confidence: 83%

Section: Discussionmentioning

confidence: 99%

Does Somatostatin-14 Have an Impact on Gastric Fistula After Laparoscopic Sleeve Gastrectomy?

et al. 2014

View full text Add to dashboard Cite

show abstract

“…Next, a 28-38 Fr bougie is passed by the anesthesiologist and the stomach is then stapler-divided cephalad parallel to lesser curvature. At the Gastro-Esophageal (GE) junction, the surgeon divides the gastric sleeve a few mm lateral to the angle of His; the cardia and left crus are explicitly avoided and not dissected, unlike in the Laparoscopic Sleeve Gastrectomy (LSG) [16][17][18].…”

Section: Creation Of the Pouchmentioning

confidence: 99%

Mini-Gastric Bypass for Bariatric Surgery Increasing Worldwide

Deitel¹

2016

Austin J Surg

View full text Add to dashboard Cite

show abstract

“…[3] Leak is the most important complication after LSG with reported rates between 0.7-5%. [4] Prompt diagnosis and aggressive treatment are essential to minimize chronic gastric fistula, multiple organ failure and related mortality rates. [5] Computed tomography is not only useful in the dignosis but also is may be useful treatment with drainage.…”

Section: Introductionmentioning

confidence: 99%

Conservative management of leakage after laparoscopic sleeve gastrectomy

Ertuğrul¹

2018

Laparosc Endosc Surg Sci

View full text Add to dashboard Cite

Laparoscopic sleeve gastrectomy (LSG) is a common surgical procedure for the treatment of morbid obesity. Severe complications may result with significant morbidity and mortality. Staple-line leakage is a rare, but important, complication. Here we present the case of a patient with staple-line leakage after LSG who was treated conservatively. The patient was a 36-year-old female with a body mass index of 43. LSG was performed. The postoperative course was uneventful and the patient was discharged on postoperative day 3. She presented with fever and back pain on postoperative day 5. An intermediate, type 2 staple-line leak was confirmed with computed tomography (CT). The patient was treated conservatively. The patient was well 1 year after the initial treatment and a follow-up CT confirmed complete resolution. Leakage and related morbidity and mortality after LSG may be a challenge for the patient and the surgeon. Early diagnosis and aggressive treatment is essential to overcome potential serious consequences. In some selected patients, a conservative approach with close observation may help to manage leakage after LSG.

show abstract

Sleeve Gastrectomy Severe Complications: Is It Always a Reasonable Surgical Option?

Abstract: LSG exposes severe complications occurring in patients with benign condition. Endoscopic stents entail high failure rate. Total gastrectomy is required in one third of the cases.

Cited by 115 publications

References 34 publications

Does Somatostatin-14 Have an Impact on Gastric Fistula After Laparoscopic Sleeve Gastrectomy?

Does Somatostatin-14 Have an Impact on Gastric Fistula After Laparoscopic Sleeve Gastrectomy?

Mini-Gastric Bypass for Bariatric Surgery Increasing Worldwide

Conservative management of leakage after laparoscopic sleeve gastrectomy

Contact Info

Product

Resources

About